Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)

Market Cap	4.23B +17.5%
Revenue (ttm)	1.05B -7.4%
Net Income	130.40M +186.3%
EPS	0.33 +209.2%
Shares Out	401.74M
PE Ratio	31.49
Forward PE	n/a
Dividend	0.07 (0.66%)
Ex-Dividend Date	n/a

Volume	9,828,756
Average Volume	7,858,778
Open	10.17
Previous Close	10.42
Day's Range	10.17 - 10.55
52-Week Range	7.38 - 13.56
Beta	0.48
RSI	57.45
Earnings Date	Apr 24, 2026

About SHE:300434

Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. The company offers over-the-counter drugs, prescription drugs, raw materials and health foods. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company produces, installs, and maintains special equipment. It also imports and exports spare parts, raw, and auxili...

• Industry: Industrial Distribution
• Sector: Industrials
• Founded: 1962
• Employees: 1,937
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300434

Financial Performance

In 2024, SHE:300434's revenue was 1.10 billion, a decrease of -8.84% compared to the previous year's 1.21 billion. Earnings were 91.76 million, a decrease of -27.29%.